We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Information for manufacturers of medical devices about reporting adverse incidents and field safety corrective actions to the MHRA.
How marketing authorisation holders should inform MHRA of a signal or an ADR to a medicine.
Application form ADV1: registration of a person in adverse possession.
Application form ADV2: register as a person to be notified of an application for adverse possession.
Report a problem ('adverse incident') with a medical device or medicine to MHRA using the Yellow Card Scheme
Form NAP: notice to the registrar in respect of an adverse possession application.
Urgent and clinically significant safety updates arising from pharmacovigilance data, including reported adverse events, for veterinary medicines authorised in the UK.
Increased discussion of suspected adverse events in social media following use of Arthramid Vet in horses.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).